Exchange: NASDAQ·Updated 07:51 PM EDT
ATYR logo

ATYR aTyr Pharma, Inc

$0.2462
$0.0091
(3.56%)
Today
Closed $0.2462
$0.0007
(0.28%)
After Hours
EarningsNov 5
Mkt Cap$25.04M
Vol1M

About ATYR

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
41

Bearish Sentiment

How do you feel about ATYR?

taa100
$ATYR short sellers are more scared than long investors because they can lose indefinitely as soon as this will move just a little bit you will see it move very fast remember what I'm saying
1
4
BullishStockCatcher
$ATYR FDA News 🗞️Adding✅ aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis 💹
1
4
stefano62
$ATYR this week Is the week tò received FDA respinse tò the new P3 trial. It can drop ny day
7
Houzehero
$ATYR +5.28% on a risk-off day when the Nasdaq ends down 1.13%, Brent futures up to $103, and the 10 yr at 5.1%. Seems like the street heard a whisper.
1
3
lifeonthewater
$ATYR Man with that kind of VOLUME and still held DOWN?? Baby wants to FLY….. Release meeee
5
focafoca99
$ATYR reached alignment with the FDA on its Phase 3 protocol for efzofitimod in pulmonary sarcoidosis.
5
stefano62
$ATYR the today drop have no sense unless there Is a leacksge about FDA respinse and the resonnse requires huge protocol modification before starting the recritment.....
5
bigron8671
$ATYR I'm not letting them get all the shares on the cheap I'm slapping the ask again today .If they want them and cheap then so do I...Hold for Gold
4
MyDogKnowsStocks
$ATYR People keep saying the news today was good. It wasn’t bad, but not the same as FDA approval.
1
1
Houzehero
$ATYR The people on here whining about such trivial things like a reverse split or the need for financing are blind to the bigger picture. The Connect Phase 2, top-line data drops in Q1. If they knock this for six, it will validate the newly designed Efzo-Fit trial and the same people whining now will be either adding or re-entering alongside major healthcare funds.
4
stefano62
$ATYR this Is Crazy.. I understood the rule "sell the news", but normally that rule After the other One "buy the rumors" , but this ticker plunge from .5 tò.37 in the post two weeks....
1
1
Bigbossmann
$ATYR $90M cash and cash equivalents and only a $37M MC. This is going to be very interesting to say the least! This is one for the long bucket!
4
__Godzilla__
$ATYR Nothing that is happening is a surprise. The market is waiting for/expecting a reverse split and dilution and is repricing accordingly.
2
Houzehero
$ATYR The R/S ensures Nasdaq compliance and financing funds the trial. Neither changes the underlying value of the asset. They’re hurdles to navigate, not value-creation events. That will only come from Connect and the newly designed Phase 3.
3
Ucke77
$ATYR Bullish? You can only laugh at this sentiment; it's utter rubbish. This will probably be my second dead weight in my portfolio after Nucana, following the RS.
1
mimiwor
$ATYR This is pulling back on fears of a rate hike… They won’t need an offering until around this time next year. How dumb can the market be? The catalyst is that the clinical program has moved forward to the next stage…
1
bob397
$ATYR Who Knows a 1-10 might skate by though 1-50 will be bad for long time share holders it will shut them out completely due the math
3
bigron8671
$ATYR They arent going to let this rise until after the split. I hopeful for good news 🙌 after .
2
CarloM
$ATYR what news you 🫛 of s. :) event im bulish, but what news. P2 maybe q1 and after that straight dilution to get some money for p3. And still it will be dead cat till 29 minimum.
2

Advertisement|Remove ads.